Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis

This publication has 37 references indexed in Scilit:

• Improvement of Some Blood Coagulation Factors in Cirrhotic Patients Treated with Low Doses of Heparin
  Scandinavian Journal of Haematology, 2009
• Prevalence of hyperfibrinolysis in patients with liver cirrhosis
  Fibrinolysis, 1993
• Hyperfibrinolysis Resulting from Clotting Activation in Patients with Different Degrees of Cirrhosis
  Hepatology, 1993
• Clotting Abnormalities in Chronic Liver Disease
  Digestive Diseases, 1992
• A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis
  Gastroenterology, 1991
• Disseminated intravascular coagulation in cirrhosis
  Hepatology, 1989
• The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor
  Blood, 1987
• In vivo metabolism of human tissue‐type plasminogen activator
  Scandinavian Journal of Haematology, 1984
• Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhosis
  British Journal of Haematology, 1982
• Fibrinogen Survival in Cirrhosis: Improvement by 'Low Dose' Heparin
  Annals of Internal Medicine, 1975